RNU7-185P

Across TCGA pan-cancer cohorts, RNU7-185P RNA is linked to patient survival in 4 of 34 cancer types, making it the most broadly survival-associated RNU7-185P data layer.

The strongest signal is observed in esophageal carcinoma (ESCA), where higher RNU7-185P RNA is associated with better overall survival. In most high-consensus cancer types, elevated RNU7-185P expression acts as an unfavorable survival marker, although some lineages such as ESCA show a favorable association.

ESCA, PAAD, and STAD are the cancer types where RNU7-185P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
ESCA	OS	Tertile	All	1.000	0.469	.010	54	view →
PAAD	OS	Tertile	All	0.216	0.613	.040	18	view →
STAD	DFS	Tertile	All	0.491	0.665	.042	9	view →
BRCA	OS	Tertile	All	0.749	0.925	.024	6	view →

Pink = unfavorable, green = favorable. Showing the 4 strongest of 4 lineages.

RNU7-185P–ESCA (OS)

Open the ESCA breakdown →